Pain Management for Patients Suffering from Sickle Cell Disease (SCD); Overview

Eman Ahmed Alshikh, Duaa Abdulrazaq Alshikh, Zahra Ali Alribh, Zainab Ali Ghallab, Fatimah Mohammed Alnemer

Abstract: SCD is a quadrumvirate of pain syndromes, anemia and its sequelae, organ failure, including infection, and comorbid conditions. Pain, however, is the insignia of SCD and controls its medical image throughout the life of the patients. The purpose of our study is to examine the complications of pain in SCD and the management of pain throughout this disease, also we aimed to evaluate the different approaches of pain management through different guidelines. We have performed overview study through review the literature in pain assessment among patients with SCD, and that’s through electronic search within different databases; MIDLINE, CINAHL, and EMBASE, for all articles discussing this topic up to November 2016, we limited our search to those studies written in the English language, describe treatment of humans, and contain original data. Management of SCD continues to be mainly palliative in nature, including encouraging, symptomatic, and preventive methods to therapy. There are 3 significant of sickle cell pain: severe, persistent, and neuropathic pain. The severe painful episode is the insignia of the disease and the most common reason for hospitalization. Its management requires making use of pharmacologic and nonpharmacologic techniques. Pain management need to follow particular concepts that include an assessment stage, treatment stage, reassessment phase, and modification phase. Keywords: MIDLINE, CINAHL, and EMBASE, SCD. Title: Pain Management for Patients Suffering from Sickle Cell Disease (SCD); Overview Author: Eman Ahmed Alshikh, Duaa Abdulrazaq Alshikh, Zahra Ali Alribh, Zainab Ali Ghallab, Fatimah Mohammed Alnemer International Journal of Healthcare Sciences ISSN 2348-5728 (Online) Research Publish Journals

Vol. 4, Issue 2, October 2016 – March 2017

Citation
Share : Facebook Twitter Linked In

Citation
Pain Management for Patients Suffering from Sickle Cell Disease (SCD); Overview by Eman Ahmed Alshikh, Duaa Abdulrazaq Alshikh, Zahra Ali Alribh, Zainab Ali Ghallab, Fatimah Mohammed Alnemer